Bridging the Gap: Aligning Clinical R&D with Commercial Goals

Throughout my two decades in Clinical R&D, I've been privileged to receive Outlook invites from my Commercial counterparts. These invitations vary in timing, arriving as early as before a phase 3 study's database lock or as late as the drafting of high-level documents for an NDA. Reflecting on these experiences, I used to joke with my Clinical R&D colleagues about Commercial expecting us to pull a rabbit out of a hat. Yet, upon deeper contemplation, I realized that perhaps we should be capable of such feats after all. After all, isn't a magic trick essentially a well-thought-out strategy aimed at delivering precisely what the audience desires? In our context, the Commercial team seeks to leverage our scientific inquiry to substantiate key promotional claims and confer commercial legitimacy upon our product to our stakeholders’ desires.